newsfilter
← Latest News
GlobeNewswire·

Ascendis Pharma to Participate in the Jefferies London Healthcare Conference

  • Ascendis Pharma A/S executives will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 17, 2026.
  • The event will commence at 11:30 a.m. Greenwich Mean Time (GMT), 6:30 a.m. Eastern Time, or 3:30 a.m. Pacific Time in London, United Kingdom.
  • A live webcast of the presentation will be accessible via the Investors & News section of the Ascendis Pharma website at investors.ascendispharma.com.
  • A replay of the webcast will be available on the same website for 30 days following the event's conclusion.
  • Ascendis Pharma is a global biopharmaceutical company headquartered in Copenhagen, Denmark, with facilities in Europe & the United States.
  • The company utilizes its TransCon technology platform to develop therapies aimed at addressing unmet medical needs.
  • The press release includes forward-looking statements regarding future operations, plans, objectives, & the application of TransCon technology.
  • Actual results may differ materially from forward-looking statements due to risks such as regulatory delays, clinical trial outcomes, manufacturing issues, market acceptance, & geopolitical factors.
  • Investor & media contacts for Ascendis Pharma are Chad Fugere & Melinda Baker, reachable via phone at +1 (650) 519-7494 & +1 (650) 709-8875 respectively.
Company
Ascendis Pharma, LLC
Keywords
Nasdaq:ASND, Ascendis Pharma, LLC